Cargando…
Early Cytokine Signatures of Hospitalized Mild and Severe COVID-19 Patients: A Prospective Observational Study
BACKGROUND: The severe manifestation of coronavirus disease 2019 (COVID-19) is known to be mediated by several cytokines and chemokines. The study aimed to compare the early cytokine profile of mild and severe COVID-19 patients to that with COVID-19-like symptoms and tested negative for Severe Acute...
Autores principales: | Alfadda, Assim A, Siddiqui, Khalid, Rafiullah, Mohamed, AlKhowaiter, Mohammad, Alotaibi, Naif, Alzahrani, Musa, Binkhamis, Khalifa, Youssef, Amira M, Altalhi, Haifa, Almaghlouth, Ibrahim, Alarifi, Mohammed, Albanyan, Saleh, Alosaimi, Mohammed F, Isnani, Arthur, Nawaz, Shaik S, Alayed, Khalid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292607/ https://www.ncbi.nlm.nih.gov/pubmed/37377977 http://dx.doi.org/10.2147/JIR.S408663 |
Ejemplares similares
-
Clinical and biochemical characteristics of people experiencing post-coronavirus disease 2019-related symptoms: A prospective follow-up investigation
por: Alfadda, Assim A., et al.
Publicado: (2022) -
Clinical and biochemical characteristics and outcomes of suspected COVID-19 hospitalized patients: RT-PCR swab positive and negative comparison
por: Alfadda, Assim A., et al.
Publicado: (2021) -
Low Circulating Free Triiodothyronine Levels are Associated with the Progression of Diabetic Nephropathy in Patients with Type 2 Diabetes
por: Siddiqui, Khalid, et al.
Publicado: (2022) -
Islet Autoantibodies to Pancreatic Insulin-Producing Beta Cells in Adolescent and Adults with Type 1 Diabetes Mellitus: A Cross-Sectional Study
por: Siddiqui, Khalid, et al.
Publicado: (2023) -
The association of cell adhesion molecules and selectins (VCAM-1, ICAM-1, E-selectin, L-selectin, and P-selectin) with microvascular complications in patients with type 2 diabetes: A follow-up study
por: Siddiqui, Khalid, et al.
Publicado: (2023)